Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
In a statement released last week, the Centers for Medicare and Medicaid Services said that lowering the cost of prescription drugs is a top priority for the Trump administration. CMS added that ...
If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...
Donald Trump’s second term brings major health care shifts with RFK Jr. leading HHS and deregulatory changes ahead. industry ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare. Medicare targets 15 more drugs for price negotiations -- including ...